Serum Institute’s HPV vaccine Cervavac receives WHO prequalification
Inclusion on the WHO list allows Cervavac to be procured by U.N. agencies. The vaccine targets four HPV types and is indicated for girls and boys aged 9 through 26 years
More news in Industry
IRDAI imposes ₹2 cr penalty on Star HealthJewellery demand remains resilient for Q3 despite gold price surge
U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in VizagGarment exporters urged to focus on financial disciple and have strategic foresight to capture orders